Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 10.74
-0.47 (-4.19%)
Jul 9, 2026, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 7.69 billion as of July 9, 2026. Its market cap has increased by 15.05% in one year.
Market Cap
7.69B
Enterprise Value
5.70B
Revenue
681.17M
Ranking
n/a
PE Ratio
109.13
Stock Price
10.74
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has decreased from 8.71B to 7.69B, a decrease of -11.66%. That is a compound annual growth rate of -2.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 7.69B | -12.03% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TenNor Therapeutics (Suzhou) | 10.38B |
| HBM Holdings | 10.13B |
| Everest Medicines | 10.07B |
| Nanjing Leads Biolabs | 10.00B |
| CARsgen Therapeutics Holdings | 9.51B |
| Suzhou Ribo Life Science | 8.84B |
| CStone Pharmaceuticals | 8.73B |
| Lepu Biopharma | 8.21B |